Apostrophe Azelaic Acid 15% prescription cream in white pump bottle
Strong choice for Acne
What Makes This Different

This was one of the few teledermatology-prescribed azelaic acid formulations that combined prescription-strength 15% azelaic acid with 4% niacinamide in a single compounded cream. The pairing of these two actives in one step streamlined routines for acne and hyperpigmentation without requiring separate products for each concern.

Apostrophe

Apostrophe Azelaic Acid 15% Review

Prescription-Strength Multitasker
treatment cream clinical Paraben Free Fungal Acne Safe Not Cruelty Free

A well-formulated prescription azelaic acid cream that paired two proven actives in one step for acne, rosacea, and hyperpigmentation. The teledermatology convenience came at a premium, and the brand's sudden shutdown in 2025 left patients scrambling — but the formula itself was genuinely effective for those who used it.

—
30 g
4.2 ★★★★★
350 reviews
Made in United States Launched 2019 All-year use PAO: 6 months
Buy at Amazon ♥

Because Apostrophe was a teledermatology platform that shut down in March 2025, public feedback is capped at the roughly 350 reviews gathered during its 2019–2025 run. The 15% azelaic acid active is heavily studied, but this particular compounded cream was never reviewed widely outside the platform, so the score rests mostly on formulation analysis.

Verdicts

How well it fits each concern

Verdict by concern tap a concern for the case

Strong choicefor AcneAzelaic Acid is an approved or monograph active for acne; this cream carries it at 15%.Moderate evidenceGentleNo reviews collected yet

The case for it

  1. Azelaic Acid is a first-line active — approved, monograph-listed or named in current guidelines — for this concern.
  2. It is present at an effective concentration, declared or high in the ingredient list.
  3. The formula carries none of the triggers this concern is sensitive to.

Same rule for everyone. “Strong choice” is the verdict on 1,459 of 45,024 concern verdicts across the catalog; rule R2 decided 892 of them. Unchanged since September 5, 2026, engine 5.1.1.

Brand or formulator? Disclose a concentration or correct a fact →

Show the work
Rule
R2 — A regulator- or guideline-recognised first-line active, declared at an effective strength, in a form the claim supports. · the full register
Carrying active
Azelaic Acid
Standing
first line — a regulator recognises it for this use; trials support it · per AZELEX® (azelaic acid cream) 20% (US Food and Drug Administration prescribing information, via DailyMed (National Library of Medicine)), opened July 27, 2026
Form
adequate (declared 15%) — studied range 10%, from the OTC monograph or label; needs leave-on contact; judge it after ~12 weeks
Tolerability
gentle
Row checked
against its sources on July 27, 2026 (evidence table ev-2026.09-r228)

The studies behind the evidence row

All acne products →
Strong choicefor RosaceaAzelaic Acid is an approved or monograph active for rosacea; this cream carries it at 15%.Strong evidenceGentleNo reviews collected yet

The case for it

  1. Azelaic Acid is a first-line active — approved, monograph-listed or named in current guidelines — for this concern.
  2. It is present at an effective concentration, declared or high in the ingredient list.
  3. The formula carries none of the triggers this concern is sensitive to.

Same rule for everyone. “Strong choice” is the verdict on 1,459 of 45,024 concern verdicts across the catalog; rule R2 decided 892 of them. Unchanged since September 5, 2026, engine 5.1.1.

Brand or formulator? Disclose a concentration or correct a fact →

Show the work
Rule
R2 — A regulator- or guideline-recognised first-line active, declared at an effective strength, in a form the claim supports. · the full register
Carrying active
Azelaic Acid
Standing
first line — a regulator recognises it for this use; trials support it · per FINACEA® (azelaic acid) Gel, 15% (US Food and Drug Administration prescribing information, via DailyMed (National Library of Medicine)), opened July 27, 2026
Form
adequate (declared 15%) — studied range 15%, from the row's cited source; needs leave-on contact; judge it after ~12 weeks
Tolerability
gentle
Row checked
against its sources on July 27, 2026 (evidence table ev-2026.09-r228)

The studies behind the evidence row

All rosacea products →
Good choicefor HyperpigmentationAzelaic Acid is a first-line active in current guidelines for hyperpigmentation; this cream carries it at 15%.Moderate evidenceGentleNo reviews collected yet

The case for it

  1. Azelaic Acid has trial-supported standing for this concern.
  2. It is present at an effective concentration, declared or high in the ingredient list.
  3. The formula carries none of the triggers this concern is sensitive to.

Same rule for everyone. “Good choice” is the verdict on 9,564 of 45,024 concern verdicts across the catalog; rule R5 decided 9,072 of them. Unchanged since September 5, 2026, engine 5.1.1.

Brand or formulator? Disclose a concentration or correct a fact →

Show the work
Rule
R5 — Trial-supported or guideline-supported active, adequately or plausibly dosed. · the full register
Carrying active
Azelaic Acid
Standing
supported — a current guideline names it; trials support it · per Treatment recommendations for acne-associated hyperpigmentation: Results of the Delphi consensus process and a literature review (Journal of the American Academy of Dermatology 2023;89(2):316-323 (PMID 36924935)), opened July 27, 2026
Form
adequate (declared 15%) — studied range 10%, from the OTC monograph or label; needs leave-on contact; judge it after ~12 weeks
Tolerability
gentle
Row checked
against its sources on July 27, 2026 (evidence table ev-2026.09-r228)

The studies behind the evidence row

All hyperpigmentation products →
Promisingfor Dark SpotsAzelaic Acid has trial-level evidence for dark spots but no guideline or regulatory standing yet — promising, short of a recommendation; the other actives here are not yet assessed for it.Moderate evidenceGentleNo reviews collected yet

The case for it

  1. Azelaic Acid has trial-level evidence for this concern but no guideline or regulatory standing yet.
  2. It is present at an effective concentration, declared or high in the ingredient list.
  3. The formula carries none of the triggers this concern is sensitive to.

What would change this: Guideline or regulatory standing for the active on this concern would move this from a promising bet to a recommendation.

Same rule for everyone. “Promising” is the verdict on 7,858 of 45,024 concern verdicts across the catalog; rule R9p decided 7,858 of them. Unchanged since September 5, 2026, engine 5.1.1.

Brand or formulator? Disclose a concentration or correct a fact →

Show the work
Rule
R9p — 0.5.0: 'Unproven' beside three filled dots read as one question answered twice with opposite words (7,018 rows). The chip measures standing, the dots measure trial volume; where the row carries at least one RCT or a tier-2 source (moderate dots) and the active is present at a working level, the honest word is Promising. Unproven is reserved for plausible-standing rows with limited or weak evidence, or an under-dosed form. Same rank as Unproven — a bet either way; the dots order them. · the full register
Carrying active
Azelaic Acid
Standing
plausible — trials support it
Form
adequate (declared 15%) — studied range 10%, from the OTC monograph or label; needs leave-on contact; judge it after ~12 weeks
Tolerability
gentle
Row checked
against its sources on July 17, 2026 (evidence table ev-2026.09-r228)

The studies behind the evidence row

All dark spots products →

Also listed for Rough Texture and Dullness — the actives here (Azelaic Acid, Niacinamide, Aloe Vera, Vitamin E) are in our research queue for those concerns; there is no verdict until their evidence rows are written. That is a gap in our table, not a mark against the product.

A verdict is DermApproved’s assessment of how well a product’s ingredients fit a concern — never a claim about what the product treats. Evidence dots and collected reviews sit beside it and are never blended in. Rules 0.5.1 · evidence table ev-2026.09-r228 · how we decide

Assessment

Pros & Cons

Pros

  • ✓ Prescription-strength 15% azelaic acid with proven efficacy across acne, rosacea, and hyperpigmentation
  • ✓ Smart niacinamide 4% pairing provides complementary barrier support and additional brightening
  • ✓ Pregnancy and breastfeeding safe — one of the few prescription-strength options available
  • ✓ Clean minimal vehicle with no fragrance, parabens, or unnecessary irritants
  • ✓ Addresses multiple skin concerns simultaneously in a single product step
  • ✓ Matte lightweight finish layers well under moisturizer and sunscreen without pilling
  • ✓ Airless pump packaging maintains formula integrity and ensures hygienic dispensing

Cons

  • ✗ Brand was discontinued in March 2025, making this product no longer available
  • ✗ Slow onset of visible results — meaningful acne clearing requires 8-12 weeks minimum
  • ✗ Premium teledermatology pricing made this significantly more expensive than generic alternatives
  • ✗ Initial tingling and warmth during the first two weeks can be uncomfortable for sensitive skin
  • ✗ Compounded formulation lacks the independent clinical data that FDA-approved branded azelaic acids have
Review

Full Review

There is a particular kind of frustration that comes with finding a skincare product that genuinely works for you, only to have it yanked away. For the patients who relied on Apostrophe's Azelaic Acid 15% cream, March 2025 delivered exactly that gut punch when Hims & Hers — the parent company that had acquired Apostrophe for a cool $190 million in 2021 — decided to shutter the entire platform to focus on its booming weight loss business. The prescription skincare equivalent of your favorite restaurant closing to become a juice bar.

But before the obituary, the formula itself deserves its due. Apostrophe's Azelaic Acid 15% was a compounded prescription cream that combined two dermatological heavyweights: azelaic acid at full prescription strength and niacinamide at a clinically relevant 4%. The pairing was smart. Azelaic acid does the heavy lifting — killing acne-causing bacteria, normalizing the rate at which skin cells shed inside pores, and inhibiting tyrosinase to fade dark spots. Niacinamide reinforces from the flanks, calming inflammation, reducing sebum production, and strengthening the moisture barrier so the azelaic acid can do its work without leaving the skin compromised.

The vehicle was deliberately minimal. Aloe vera juice as the primary soothing agent, caprylic/capric triglycerides for a touch of emollience, tocopheryl acetate for antioxidant backup, and phenoxyethanol as the sole preservative. No fragrance, no unnecessary botanical extracts, no Instagram-friendly but dermatologically questionable additions. This was a formula designed by dermatologists who wanted their patients to use it consistently without their skin throwing a fit.

Application was straightforward. The white cream dispensed from an airless pump — a thoughtful packaging choice that prevented contamination and ensured consistent dosing. It spread easily without dragging and absorbed within about a minute, leaving behind a matte, barely-there finish that layered well under moisturizer and sunscreen. The initial tingling that most azelaic acid users experience was present but manageable, typically subsiding within the first two weeks of use.

Where this product truly earned its following was in the combination of conditions it could address simultaneously. A patient dealing with hormonal acne along the jawline and lingering dark spots from previous breakouts could treat both with a single product, applied once or twice daily. Someone with mild rosacea and occasional breakouts found that the dual anti-inflammatory action of azelaic acid and niacinamide calmed both concerns without the irritation that retinoids or benzoyl peroxide might trigger. And critically, this was one of the few prescription-strength options safe for use during pregnancy — a gap that few other actives could fill.

The clinical evidence supporting 15% azelaic acid is robust and spans decades. Studies have demonstrated comparable efficacy to adapalene 0.1% for acne with significantly less irritation, meaningful improvements in papulopustular rosacea rivaling metronidazole, and measurable lightening of post-inflammatory hyperpigmentation. The addition of niacinamide at 4% was not merely trendy; multiple controlled trials have shown niacinamide's ability to reduce sebum excretion, improve skin barrier function, and provide its own independent brightening effect through inhibition of melanosome transfer.

The limitations were real, however. Azelaic acid at any concentration is not a fast worker. Users expecting the rapid visible peeling of a retinoid or the overnight bacterial knockout of benzoyl peroxide found azelaic acid's gradual, steady approach frustrating. Eight to twelve weeks for meaningful acne improvement, potentially sixteen or more for significant pigmentation fading — that is a long time to wait, especially when you are paying a subscription premium for the privilege.

And the cost was the elephant in the room. Apostrophe's teledermatology model — consultation fee plus ongoing prescription costs — placed this compounded cream at a significant markup over what a patient might pay for generic azelaic acid gel through traditional channels with insurance. The convenience of skipping the dermatologist's office was genuine, but convenience has always been an expensive luxury in healthcare.

The texture and user experience, while pleasant, were nothing remarkable. This was a workmanlike cream that did its job without fanfare. It did not have the elegant sensory profile of a Korean beauty serum or the satisfying slip of a high-end treatment. It was clinical in the best and most literal sense — effective, unembellished, and focused entirely on outcomes.

For the patients who found their rhythm with this product — who had navigated the initial tingling, waited through the slow weeks, and finally arrived at clearer, more even-toned skin — the brand's closure was a genuine loss. The good news is that azelaic acid at 15% is available through other channels, and the niacinamide can easily be added as a separate step. The formula was excellent, but the ingredients are not proprietary. What Apostrophe provided was the combination and the convenience, and while both are replaceable, the sudden disappearance reminded patients that in DTC healthcare, your prescription is only as stable as the parent company's quarterly earnings call.

Formula

Key Ingredients

The hero actives that drive this product's performance.

IngredientFunctionEvidence
Azelaic Acid (15%) The cornerstone active at prescription strength, working as both a tyrosinase inhibitor to fade post-inflammatory hyperpigmentation and an antimicrobial that reduces Cutibacterium acnes proliferation. At 15%, it also normalizes keratinization to prevent pore clogging, complemented by the niacinamide for enhanced brightening. Regulator-approved for Rosacea · well-established certainty
Niacinamide (4%) Supports the azelaic acid by strengthening the skin barrier through increased ceramide production, while independently reducing sebum output and calming inflammation. The 4% concentration is optimized to enhance the azelaic acid's anti-redness effects without competing for absorption. Emerging for Hyperpigmentation
Aloe Barbadensis Leaf Juice Serves as the soothing counterbalance to the azelaic acid's potential for initial tingling, providing anti-inflammatory polysaccharides that help the skin adjust to the active without excessive irritation during the break-in period. Not yet assessed
Tocopheryl Acetate A stabilized form of vitamin E that provides antioxidant protection to the formulation while supporting the skin barrier repair that the azelaic acid and niacinamide initiate, helping to reduce oxidative stress in inflamed acne-prone skin. Not yet assessed
Full INCI List

Active Ingredients: Azelaic Acid (15%), Niacinamide (4%). Inactive Ingredients: Aloe Barbadensis Leaf Juice, C13-14 Isoparaffin, Caprylic/Capric Triglyceride, Water, Laureth-7, Phenoxyethanol, Polyacrylamide, Tocopheryl Acetate, Triethylene Glycol.

Safety & Formulation Facts
✓ Pregnancy Safe ✓ Fragrance Free✓ Alcohol Free✓ Oil Free✓ Silicone Free✓ Paraben Free✓ Sulfate Free✗ Cruelty Free✗ Vegan✓ Fungal Acne Safe
Potential Irritants
Azelaic Acid (tingling/burning on initial use)Laureth-7
Compatibility

Skin Match

Routine Step

treatment

Time of Day

AM & PM

Layering Tips

Apply a thin layer after cleansing and toning but before moisturizer. Can be used twice daily but many dermatologists recommend starting once daily in the evening to assess tolerance. Wait 1-2 minutes before layering moisturizer.

Results Timeline

Mild tingling or warmth on initial application is normal and typically resolves within 2-4 weeks. Early improvements in skin texture and reduced redness may appear at 2-4 weeks. Significant acne clearing and pigmentation fading typically require 8-12 weeks of consistent use. Maximum results for melasma and post-inflammatory hyperpigmentation may take 16-24 weeks.

Pairs Well With
Gentle hydrating cleanserLightweight moisturizerBroad-spectrum sunscreen
Planning a combo? Check it against what you already use
Sample AM Routine
  1. Gentle cleanser
  2. Apostrophe Azelaic Acid 15%
  3. Lightweight moisturizer
  4. Broad-spectrum sunscreen SPF 30+
Sample PM Routine
  1. Gentle cleanser
  2. Hydrating toner (optional)
  3. Apostrophe Azelaic Acid 15%
  4. Moisturizer
Evidence

Science & Expert Perspective

The Science

Azelaic acid at 15% concentration is among the most versatile prescription actives in dermatology, supported by decades of clinical evidence. A 2023 systematic review by King et al. published in the Journal of Cosmetic Dermatology evaluated azelaic acid's efficacy across acne, rosacea, melasma, and skin aging, concluding that 15-20% concentrations produced clinically meaningful improvements across all four indications with a favorable safety profile.

For acne specifically, azelaic acid works through a triple mechanism: antimicrobial activity against Cutibacterium acnes, normalization of follicular keratinization (preventing the clogged pores that initiate breakouts), and anti-inflammatory effects that reduce the redness and swelling of active lesions. A comparative study demonstrated that azelaic acid 15% gel achieved acne lesion reduction comparable to adapalene 0.1% gel over nine months, with significantly lower irritation scores — a meaningful advantage for patients who cannot tolerate retinoids.

The combination with niacinamide at 4% in this formulation is pharmacologically rational. Niacinamide independently reduces sebum production by modulating lipid synthesis in sebocytes, strengthens the skin barrier through increased ceramide production, and inhibits melanosome transfer from melanocytes to keratinocytes — providing a complementary brightening mechanism to azelaic acid's direct tyrosinase inhibition. While no published trial has evaluated this specific Apostrophe formulation, the individual actives at these concentrations each have robust evidence supporting their efficacy.

For rosacea, multiple randomized controlled trials have established 15% azelaic acid as a first-line treatment for papulopustular subtype, with efficacy comparable to or exceeding metronidazole 0.75% gel. A 2024 study published in the Journal of Dermatological Treatment confirmed that azelaic acid 15% significantly reduced post-acne hyperpigmentation indices and melanin content compared to vehicle control, reinforcing the ingredient's dual utility for both active lesions and their aftermath.

Dermatologist Perspective

Dermatologists have long valued azelaic acid as a versatile and well-tolerated treatment option, particularly for patients who cannot use retinoids due to pregnancy, breastfeeding, or sensitivity concerns. Working dermatologists often find that 15% azelaic acid occupies a unique therapeutic niche — it addresses acne, rosacea, and hyperpigmentation simultaneously, which few other single actives can claim. The combination with niacinamide at 4% in this formulation aligns with evidence-based dermatological practice, as both ingredients have complementary mechanisms of action. Dermatologists commonly advise starting with once-daily evening application and titrating to twice daily as tolerance builds. The pregnancy safety profile makes this category of product especially valuable in clinical practice, where the overlap between hormonal acne and family planning is common.

Guidance

Usage & Recommendations

How to Use

Cleanse face with a gentle, pH-balanced cleanser and pat dry. Apply a pea-sized amount of the cream in a thin, even layer across the affected areas. Allow 1-2 minutes for absorption before applying moisturizer. Start with once-daily application in the evening for the first 2 weeks to assess tolerance, then increase to twice daily (morning and evening) if no significant irritation occurs. Always follow with broad-spectrum sunscreen SPF 30 or higher during the day. Avoid applying to broken skin, and discontinue temporarily if significant peeling or burning occurs.

Value Assessment

Apostrophe's pricing model was the product's most significant drawback. The teledermatology consultation fee plus ongoing prescription costs placed this compounded cream well above what patients might pay for FDA-approved azelaic acid products like Finacea through traditional dermatology with insurance. For uninsured patients, the convenience of at-home consultation and doorstep delivery had genuine value, but the per-month cost was difficult to justify when generic azelaic acid prescriptions exist. The single 30 g size with no larger options meant no economies of scale for long-term users. With the brand now discontinued, the value proposition is moot — but it serves as a reminder that convenience-based healthcare pricing does not always align with ingredient quality.

Who Should Buy

This product was ideal for anyone dealing with acne, rosacea, or post-inflammatory hyperpigmentation who wanted a prescription-strength solution without the irritation of retinoids. It was especially valuable for pregnant or breastfeeding individuals seeking safe, effective acne treatment.

Who Should Skip

Those with very tight budgets had better options through traditional prescriptions with insurance. Anyone needing rapid visible results would find the slow onset frustrating compared to retinoids or benzoyl peroxide. With the brand now discontinued, everyone must look elsewhere.

Ready to try Apostrophe Azelaic Acid 15%?

Buy at Amazon ♥
Details

Product Details

Texture

Lightweight white cream with a smooth, non-greasy consistency that spreads easily and absorbs within a minute

Scent

Essentially unscented with a very faint clinical/pharmaceutical note

Packaging

30 g white pump bottle with Apostrophe branding, airless pump design for hygienic dispensing

Finish
mattenon-greasylightweight
What to Expect on First Use

Expect mild tingling or a warm sensation for the first 1-2 weeks, which is completely normal with azelaic acid at prescription strength. The cream applies smoothly and doesn't leave a white cast. Most users report the tingling subsides as the skin acclimates. Some initial dryness may occur if used twice daily from the start.

How Long It Lasts

2-3 months with once to twice daily facial application

Period After Opening

6 months

Opened yours? Track the toss-by date
Best Season

All Year

Background

The Story Behind This Product

Apostrophe built its reputation on making prescription-strength actives accessible through teledermatology, bypassing traditional dermatologist wait times. This azelaic acid formula became popular among patients seeking a pregnancy-safe alternative to retinoids for acne and pigmentation. The brand was acquired by Hims & Hers in 2021 for $190 million, but was abruptly shut down in March 2025 as the parent company shifted focus to weight loss offerings.

About Apostrophe Established Brand (5–20 years)

Apostrophe launched in 2019 as a rebrand of YoDerm (founded 2012), a teledermatology platform connecting patients with board-certified dermatologists who prescribed customized compounded formulations. The brand was acquired by Hims & Hers for $190 million in 2021 and was shut down in March 2025.

Brand founded: 2012 · Product launched: 2019
Myth vs. Reality

Common Myths

Myth

Azelaic acid is too weak to treat real acne — you need benzoyl peroxide or retinoids.

Reality

Clinical trials show 15% azelaic acid achieves comparable acne reduction to adapalene 0.1% with significantly less irritation. It works through multiple mechanisms including antimicrobial activity and keratolysis.

Myth

Prescription azelaic acid from teledermatology platforms is the same as pharmacy-compounded generics.

Reality

Apostrophe's formulation was specifically compounded with niacinamide 4% and aloe vera as a vehicle, which differs from generic azelaic acid gels like Finacea that use different inactive ingredients and lack the niacinamide boost.

FAQ

Frequently Asked Questions

Is Apostrophe Azelaic Acid 15% still available?

No. Apostrophe was shut down by its parent company Hims & Hers in March 2025. Patients who were using this formula were advised to transfer their prescriptions to other providers. Similar azelaic acid 15% formulations are available through other teledermatology platforms and as branded products like Finacea.

Can you use azelaic acid 15% during pregnancy?

Yes — azelaic acid is classified as Category B for pregnancy and is one of the few prescription-strength acne treatments considered safe during pregnancy and breastfeeding. This Apostrophe formulation's niacinamide is also pregnancy-safe, making the entire formula suitable for expectant mothers dealing with hormonal acne.

How long does azelaic acid 15% take to show results?

With this formulation's 15% azelaic acid and 4% niacinamide combination, early improvements in skin texture and redness typically appear within 2-4 weeks. Significant acne clearing usually requires 8-12 weeks, and meaningful fading of post-inflammatory hyperpigmentation can take 16-24 weeks of consistent use.

Can you use azelaic acid with retinol or tretinoin?

Yes, and many dermatologists recommend this combination. Azelaic acid and retinoids work through different mechanisms and can complement each other. Apostrophe even offered combination formulations with tretinoin and azelaic acid together. When using separately, apply them at different times of day to minimize irritation.

Does azelaic acid 15% cause purging?

Mild purging is possible in the first 2-4 weeks as azelaic acid's keratolytic action brings existing microcomedones to the surface faster. This is usually less severe than purging from retinoids. The niacinamide in this Apostrophe formula helps mitigate inflammation during any adjustment period.

What are alternatives to Apostrophe Azelaic Acid 15% now that it's discontinued?

Finacea (azelaic acid 15% gel) is the most widely available branded prescription alternative. Other teledermatology platforms like Curology and Dermatica also offer custom azelaic acid formulations. For OTC options, The Ordinary Azelaic Acid Suspension 10% provides a lower concentration without a prescription.

Reviews

What Reviewers Tend to Say

Recurring themes our editors read across retailer reviews of this product — summaries in our words, not quotations, and not a substitute for your own patch test.

Common Praise

Effective for stubborn acne and post-acne marks

Gentle enough for sensitive skin

Noticeable texture improvement within weeks

Pregnancy-safe prescription option

Common Complaints

Tingling and warmth on initial application

Subscription pricing felt expensive

Slower results compared to tretinoin for acne

Brand was abruptly discontinued

Notable Endorsements
Board-certified dermatologists prescribed through Apostrophe platformRecommended for pregnancy-safe acne treatment